Cargando…
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
In order to identify reasons for treatment failures when using targeted therapies, we have analyzed the comprehensive molecular profiles of three relapsed, poor-prognosis Burkitt lymphoma cases. All three cases had resembling clinical presentation and histology and all three patients relapsed, but t...
Autores principales: | Polaskova, Kristyna, Merta, Tomas, Martincekova, Alexandra, Zapletalova, Danica, Kyr, Michal, Mazanek, Pavel, Krenova, Zdenka, Mudry, Peter, Jezova, Marta, Tuma, Jiri, Skotakova, Jarmila, Cervinkova, Ivana, Valik, Dalibor, Zdrazilova-Dubska, Lenka, Noskova, Hana, Pal, Karol, Slaby, Ondrej, Fabian, Pavel, Kozakova, Sarka, Neradil, Jakub, Veselska, Renata, Kanderova, Veronika, Hrusak, Ondrej, Freiberger, Tomas, Klement, Giannoula Lakka, Sterba, Jaroslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027364/ https://www.ncbi.nlm.nih.gov/pubmed/32117783 http://dx.doi.org/10.3389/fonc.2019.01531 |
Ejemplares similares
-
Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
por: Pokorna, Petra, et al.
Publicado: (2022) -
Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
por: Kyr, Michal, et al.
Publicado: (2019) -
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
por: Kýr, Michal, et al.
Publicado: (2020) -
Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?
por: Noskova, Hana, et al.
Publicado: (2020) -
Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
por: Sramek, Martin, et al.
Publicado: (2018)